PCN508 A COMPARISON OF PATIENT CHARACTERISTICS TREATED WITH NIVOLUMAB FOR RECURRENT/METASTATIC (R/M) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN GERMANY AND THE USA
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.700
https://www.valueinhealthjournal.com/article/S1098-3015(19)33078-5/fulltext
Section Title :
Section Order :
10611
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33078-5&doi=10.1016/j.jval.2019.09.700